Martin O. Tanner is a founder, managing partner, and portfolio manager of Blue Sea Investments, LLC, an event-driven long/short public-equity fund. For the past ten years, Blue Sea has focused heavily on investments in the pharmaceutical and medical device spaces, tracking patent litigation, loss of exclusivity events, FDA drug/device approvals, and other healthcare-related catalysts. From 2009 to 2018, Blue Sea generated returns to investors, net of all fees, in excess of 1100%.

Prior to founding Blue Sea Investments, Martin led the Corporate Development Group for Micron Technology, Inc., a Fortune 500 semiconductor manufacturer. In this role, Martin was responsible for M&A, venture investments, performance improvement projects, market research, and competitive intelligence. Prior to his association with Micron, Martin was a consultant at McKinsey & Company, where he led strategy and operational improvement projects, primarily for high-tech clients in the US, Asia, and Latin America.

Martin attended UCLA, receiving B.S., M.S. and Ph.D. degrees in Electrical Engineering, the latter two as a Fellow of the Semiconductor Research Corporation. He holds two US Patents and has authored or coauthored over 30 papers and presentations on semiconductor materials and device physics. Martin is an avid distance-runner who lives in Goleta, California with his wife and two children.